Pablo J Cagnoni Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 18 hours ago
Pablo J Cagnoni has an estimated net worth of at least $28.8 million*, as of yesterday. They own 268,769 shares of INCY stock. They have sold 78,420 shares of INCY stock since 2021, for an estimated $3.6 million.
Pablo J Cagnoni $INCY SEC Form 4 Insider Trading
Pablo J Cagnoni has filed a total of 3 insider trades in $INCY since 2021. Their most recent trade was a sale of 18,667 shares, made on Apr 17, 2026. Their largest trade was a sale of 18,668 shares, made on Feb 19, 2026. We estimate that they now own 268,769 shares of $INCY, worth an estimated $25.1 million.
Insider Trading at $INCY
There have been a total of 135 insider trades reported at $INCY since 2021, with 4.1 million shares purchased and 833,160 shares sold. The most active insider traders in $INCY stock have been Sheila A. Denton, Vijay K Iyengar, and Barry P Flannelly. The most recent trade was a sale of 18,667 shares reported by PABLO J CAGNONI (President, Global Head of R&D), made on Apr 17, 2026.
History of Insider Stock Trades by Pablo J Cagnoni
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
INCY
|
Sale | 18,667 | Apr 17, 2026 | April 21, 2026, 4:09 p.m. |
INCY
|
Sale | 18,667 | Mar 17, 2026 | March 19, 2026, 4:20 p.m. |
INCY
|
Sale | 18,668 | Feb 19, 2026 | Feb. 23, 2026, 5:05 p.m. |
RUBY
|
Sale | 8,448 | Feb 01, 2023 | Feb. 1, 2023, 10:41 p.m. |
RUBY
|
Sale | 7,240 | Jan 31, 2023 | Jan. 31, 2023, 10:51 p.m. |
RUBY
|
Sale | 6,730 | Feb 01, 2022 | Feb. 1, 2022, 10:20 p.m. |
$INCY Executives and Stock Owners with Insider Trades
-
Sheila A. Denton, EVP & General Counsel
-
Vijay K Iyengar, EVP, GMAPPS
-
Barry P Flannelly, EVP & General Manager US
-
Thomas Tray, Principal Accounting Officer
-
Steven H Stein, EVP & Chief Medical Officer
-
Maria E Pasquale, EVP & General Counsel
-
Dashyant Dhanak, EVP & Chief Scientific Officer
-
Paula J Swain, EVP, Human Resources
-
Michael James Morrissey, EVP, Head of Tech. Operations
-
Jonathan Elliott Dickinson, EVP, General Manager, Europe
-
Pablo J Cagnoni, President, R&D
-
Patrick A Mayes, EVP & Chief Scientific Officer
-
Paul Trower, Principal Accounting Officer
-
Pablo J Cagnoni, President, Global Head of R&D
-
Mohamed Khairie Issa, EVP, Head of US Oncology
-
Lee Heeson, EVP, Head of Incyte Intl
-
Vijay K Iyengar, EVP GPS, BD, & Licensing
-
Yao Wenqing, EVP, Head of Discovery Chem
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.